PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

Case Report

Volume 2 Issue 2

Predictors of Poor Prognosis during the 2015 Meningitis Epidemic at Niamey National Hospital

Gado Amadou Mahamadou, Boulama Malam Mamadou, Amadou Mahamane Laouali Harouna, Akilou Abdoulsalam, Mamane Daou, Ayouba Ismael Tinni, Moussa Sahada Salèye, Yacouba Nouhou, Hanki Yahayé and Adehossi Eric

January 28, 2023

View PDF

Abstract

     The countries of the Peysonnia belt are paying a heavy price for bacterial meningitis. Morbidity and mortality of bacterial meningitis is linked to certain factors.

     It is a descriptive and analytical prospective study over a period of two months from April 15 to June 15, 2015 in subjects admitted for suspected meningitis at the National Hospital of Niamey. Identifying predictors of poor prognosis during this outbreak is our goal.

     One hundred and five patients were enrolled. The majority were young. Signs of severity were coma (22.9%), seizures (12.4%), signs of focus (9.5%), shock (7.5%). Delay in management and hyperproteinrachia have also been identified as poor prognostic factors. Sequelae were balance disorders (n=20; 19%), hearing loss (n=7; 6.6%), purpura fulminans (n=13; 12.4%). There were 12 deaths or 11.4% of which 11 comas (91.66%), 2 convulsions (16.66%), 1 purpura fulminans (8.3%), 6 shock (50%), 5 signs of focus (41.66%), 8 of these patients (66.66%) came 3 days after the onset of signs.

     Poor prognosis factors were related to brain damage, shock and delayed management. Improving Niger's health system will reduce them.

Keywords: bacterial meningitis; poor prognostic factors; Niamey; Niger

References

  1. Alexis Kafando. “Evaluation of the introduction of the new A conjugate vaccine (MenAfrivac) at the national level on the epidemiology of bacterial meningitis in Burkina Faso”. University Diploma in Vaccinology, University of Bordeaux, Ecole Val de Grace (2011).
  2. WHO: Weekly Epidemiological Record: Executive Brief: WHO Position on Meningococcal Vaccines, November (2011).
  3. Yazi Mai Aiki Abdoul Aziz. “Clinical and paraclinical investigations of the probable sequelae of bacterial meningitis in Niger”. Medical Thesis No. 0 1935, Abdou Moumouni University of Niamey, (2011).
  4. Adrien Deroubaix. “Impact of desert aerosols and climate on meningitis epidemics in the Sahel”. PhD thesis, Pierre and Marie Curie University. France (2013).
  5. WHO/EMC/BAC/98.3: WHO practical guidance, Controlling meningococcal meningitis epidemics. www.who.int/emc.
  6. WHO: Weekly Epidemiological Record: Executive Brief: WHO Position on Meningococcal Vaccines, November (2011).
  7. Fati Sidikou., et al. Polymérase Chain Reaction Assay and Bacterial Meningitidis Surveillance in Remote Areas, Niger.
  8. Frasch CE, Preziosi M-P and LaForce FM. “Development of a group A meningococcal conjugate vaccine, Men Afri Vac(TM)”. Hum Vaccin Immunother 8.6 (2012): 715-24.
  9. Mamoudou Harouna Djingarey. Development and introduction of meningococcal A conjugate vaccine; Planning workshop for the introduction of the A conjugate vaccine (MenAfrivac) and operationalization of case-by-case surveillance in Burkina Faso; Bobo Dioulasso (2009).
  10. SadouKalilou Moussa. “Evaluation of the response to the meningitis epidemic in the health district of Say, Niger, 2006”. Thesis for obtaining an interuniversity diploma, in Ouidah (2007).
  11. WHO: Meningitis Weekly Epidemiological Bulletin 2010, week 48–52.
  12. WHO: Meningitis Weekly Epidemiological Bulletin 2011, Week 48–52.
  13. Sanon Adama. “Epidemiological, clinical, bacteriological and evolutionary aspects of bacterial meningitis about 179 cases at the Souro Sanou University Hospital in Bobo Dioulasso”. Thesis of Medicine, Burkina Faso (2004).
  14. A Dembele. “Purulent meningitis in newborns from 0 to 60 days in the pediatric intensive care unit of the Gabriel Touré Hospital in Bamako”. Thesis of Medicine, University of Bamako (2001).
  15. Towa Djeungoue Stéphanie Jackie. “Epidemiology of meningitis in Mali in 2007”. Thesis of Medicine, University of Bamako.
  16. Abdoulkarim Sabo. Epidemiology and treatment of purulent meningitis at the infectious diseases clinic of the CHU de Fann in Dakar about 262 cases collected from 1994 to 1997, Thesis of pharmacy, Cheick AntaDiop University of Dakar (1998).
  17. G Campagne., et al. Epidemiology of bacterial meningitis, Niamey (Niger), 1981-1996 Bulletin of World Health Organ 77.6 (1999): 499-506.
  18. Amadou Oumarou. “Purulent meningitis in children (epidemiological, clinical, etiological, therapeutic and evolutionary aspects)”. Thèse de médecine, Niamey (Niger) (1898).
  19. Barbach Youness. Management of meningitis in the emergency department of the Hassan II University Hospital – Fez (about 15 cases), Thesis of Medicine, Sidi Mohamed Ben Abdallah University of Fez, Morocco.
  20. Julie Chaix. “Community-based purulent meningitis in children: a retrospective study from 1998 to 2003 of two cohorts in Dakar, Senegal and Nancy, France”. Life Sciences [q-bio]. FFHAL-01731977 (2006).
  21. Taha MK. Meningococcal infections. EMC - Infectious Diseases 9.3 (2012): 1-17.
  22. Syrogiannopoulos GA., et al. “Dexamethasone Therapy for Bacterial Meningitis in Children: 2- versus 4-Day Regimen”. The Journal of Infectious Diseases 169.4 (1994): 853-8.
  23. Fabrice Bruneel and Michel Wolf. acute meningitis; Encyclopediamedico-surgical 17-160-C-10.
  24. V des Portes. Sequelae of bacterial meningitis in children and adults; incidences, types, methods of evaluation; Medicine and infectious diseases 39.7-8 (2009): 572-580.
  25. E Forestier. “Strategy for the management of presumed bacterial acute community-acquired meningitis in adults”. Medicine and Infectious Diseases 39.7-8 (2009): 606-614.
  26. H Ben Hamouda., et al. “Clinical and evolutionary aspects of neonatal bacterial meningitis”. Pediatrics Archive 20 (2013): 938-944.